Delivery Order SPE2DB22D3004-SPE2DB23FRD62
Award Date 8/29/23
Potential Completion Date 8/30/23
Potential Value $5.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,569.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units), with performance in Conshohocken, Pennsylvania and a completion date of September 24, 2025. This non-competitive delivery order was awarded on September 23, 2025, and represents a pharmaceutical supply requirement for federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $5,446.74 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $13,445.69 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was awarded on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $10,409.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-competitive delivery order was performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $25,905.55 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item fulfilling pharmaceutical supply...
- The Defense Logistics Agency awarded a $6,223.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562098276 IBSRELA 50 MG TABLET UU 60S. The order is to be performed in Conshohocken, Pennsylvania by September 11, 2023 to fulfill requirements under an indefinite-delivery/indefinite-quantity contract vehicle. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the specified tablets to support the...
- The Defense Logistics Agency awarded a competitively procured delivery order to AmerisourceBergen Drug Corp for approximately $6.3K for IBSRELA 50 MG tablets (60-count units). This non-set-aside contract, issued on November 18, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,810.27 to AmerisourceBergen Drug Corp for the supply of IBSRELA 50 mg tablets (60-count units) on September 22, 2025, with completion scheduled for September 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $2,244.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) with an ultimate completion date of September 30, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,971.92 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger relationship...